Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Administration of lindane at a dose of 20 mg/kg body weight/day for 15 days to male rats brought about marked growth retardation.
Succinic dehydrogenase
,
Mg2+-ATPase
and glucose-6-phosphatase activities were inhibited in different fractions of liver tissues.
Mg2+-ATPase
, alkaline phosphatase and NADH-dehydrogenase activities were also inhibited in the liver plasma membranes of the lindane treated animals. Stimulation of 5'-nucleotidase activity in liver plasma membrane was observed under lindane intoxication. Supplementation of L-ascorbic acid by separate oral administration to the lindane intoxicated rats neutralized the growth retardation and maintained almost normal values of all the enzymes studied.
...
PMID:Protective effect of L-ascorbic acid in lindane intoxicated rats. 618 53